1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


CBVmax obtained using methods 1 and 2
MethodAll Tumors, Mean (range)AC (n = 21), Mean (range)OA (n = 8), Mean (range)OD (n = 5), Mean (range)
Method 14.01 (1.54–6.99)3.30 (1.54–6.65)5.33 (3.07–6.65)5.04 (2.74–6.99)
Method 21.63 (0.70–3.51)*1.44 (0.70–2.46)1.53 (1.26–1.94)2.21 (1.47–3.51)
  • Note:—AC indicates astrocytoma; OA, oligoastrocytoma; OD, oligodendroglioma; rCBV max, maximum relative cerebral blood volume.
  • * P < .001 for method 1 versus method 2 by Wilcoxon test.